Tear this section
………………….. ……………………………………………………………………………………………………………………….……...
PROGRAM
0930-1000
Brunch/Coffee/Register
1000-1015
Welcome & Introduction
Dr Karyn Boundy
1015-1100
Multiple Pathologies in Dementia
A/Prof Michael Woodward
1100-1130
Rare Causes of Vascular Changes
on MRI Imaging
Dr Karyn Boundy
1130-1230
The Vascog Criteria for Vascular
Neurocognitive Disorders
Professor Perminder Sachdev
1230-1300
AGM (all non-pharma invited)
1300-1400
LUNCH
1400-1500
Prodromal Alzheimer Disease
Professor Howard Feldman
US Overseas Guest Speaker
1500-1540
Prodromal Alzheimer Disease Trials
A/Prof Michael Woodward
1540-1600
AFTERNOON TEA
1600-1640
Ethical Issues in Clinical Trials
A/Prof Roger Clarnette
1640-1730
Hell to Heaven: How to make
Clinical Trials work better & how
we have improved them &
Australian Clinical Trial Update
Professor Sue Kurrle & Trial Staff
1730
CLOSE / Drinks (at own expense)
AC4R
ANNUAL SEMINAR
2010
Unravelling the Complexity
of Alzheimer’s Disease and
Clinical Trials
DATE
Wednesday
22 September 2010
rd
TIME
1000–1730
VENUE
Holiday Inn Surfers Paradise
22 View Avenue
SURFERS PARADISE QLD 4217
Ph: (07) 5579 1088
ACCOMMODATION BOOKINGS: Amee TRISCARI
conf@holidayinnsurfersparadise.com.au
QUOTE: “AC4R Booking” for discounted rate
ABOUT THE SPEAKERS
DR KARYN BOUNDY (AC4R CHAIRPERSON) is A
Senior Consultant Neurologist with the Memory Unit,
Neurology & Clinical Trials at The Queen Elizabeth Hospital in
Adelaide, South Australia.
A/PROFESSOR MICHAEL WOODWARD is the Director
of the Aged Care Department at Austin Health, in Heidelberg,
where he heads their memory clinic and Medical and Cognitive
Research Unit. He specializes in dementia research and care,
and has been National Coordinator for several new therapeutic
AD trials.
PROFESSOR HOWARD FELDMAN MD, is a Professor of
Neurology, Division of Neurology, University of British
Columbia, Vancouver. He has held the positions of the Head
of Division of Neurology UBC and Vancouver Coastal Health,
Vancouver, Canada (2001-8) and has been the Director of the
Clinic for Alzheimer Disease (AD) and Related Disorders at
UBC Hospital. In 2007, he was appointed as the inaugural
Fisher Family and Alzheimer Society of British Columbia
Endowed Professor for Research in Alzheimer’s disease. He
also holds appointments as Adjunct Professor at Yale
University Department of Neurology and the McGill Centre for
Studies in Aging in Montreal.
In 2009, Dr Feldman took a leave from his academic
appointments to take on the role of Vice President and
Therapeutic Area Head in Neuroscience, Global Clinical
Research and Development at Bristol-Myers Squibb, in
Wallingford, Connecticut, where he is developing novel
pharmaceutical therapies for indications in both Neurology and
Psychiatry.
Dr. Feldman has made important contributions to his field with
his original research in the areas of mild cognitive
impairment/prodromal Alzheimer’s disease, frontotemporal
dementia and clinical diagnostic/therapeutic trials in AD. He
has been a very active clinical researcher in epidemiology,
biomarker development and experimental therapeutics in
dementia contributing over 250 publications including over
120 peer-reviewed papers. He has lectured globally and
received numerous awards for his research and clinical work.
His contributions have been profiled in Lancet Neurology in
2007 and he has been appointed as Fellow of the Canadian
Academy of Health Sciences in 2008, and the American
Academy of Neurology 2007.
REGISTRATION
PROFESSOR PERMINDER SACHDEV Scientia Professor
of Neuropsychiatry at the University of New South Wales
(UNSW) and Clinical Director of the Neuropsychiatric Institute
(NPI) (www.med.unsw.edu.au/npi), The Prince of Wales
Hospital in Sydney, Australia. He graduated from the All-India
Institute of Medical Sciences, New Delhi in 1978 and
completed his MD in Psychiatry in 1983 at that institution
before migrating to New Zealand. He then relocated to
Australia where he completed his psychiatric training and PhD
(1991) and went on to head the Neuropsychiatric Institute.
His doctorate was on the ethnopsychological concepts in Maori
culture. His early work in Neuropsychiatry was on druginduced movement disorders, in particular akathisia, tardive
dyskinesia and neuroleptic malignant syndrome. His most
recent work has been in dementia and pre-dementia
syndromes, in particular relating to neuroimaging,
neuropsychology, biomarkers and risk factors.
He has
extensively examined the outcome of psychosurgery, and is
currently involved in examining brain stimulation techniques
(TMS, DCS and VNS) for psychiatric disorders. Dr. Sachdev is
past-president
of
the
International
Neuropsychiatric
Association and inaugural Chair of the Section of
Neuropsychiatry of the Royal Australian and New Zealand
College of Psychiatrists. He has published five books and over
250 original papers in peer-reviewed journals. His most
recent books are ‘The Yipping Tiger and other tales from the
neuropsychiatric clinic’ and ‘Secondary Schizophrenia’. His Hindex is 32, and total citations were over 4000 in 2009. He
currently holds, as chief investigator, a National Health &
Medical Research Council Program Grant, an Ageing WellAgeing Productively Program Grant and a NHMRC Capacity
Building Grant in addition to many other grants. He heads the
Brain and Ageing Research Program of the University of New
South Wales: www.brainage.med.unsw.edu.au.
A/PROFESSOR
ROGER CLARNETTE is Consultant
Physician, Department Community and Geriatric Medicine,
Fremantle Hospital. He is the Director of the Memory
Evaluation Unit for the South Metropolitan Area Health Service
in Western Australia. Dr Clarnette’s research interests include
the biological, clinical and pharmacological aspects of
dementia.
PROFESSOR SUE KURRLE is a Geriatrician at the
Hornsby-Kuringai Health Service, Curran Chair of Geriatric
Medicine at University of Sydney.
Name:
__________________________________
Title:
__________________________________
Address:
__________________________________
__________________________________
 No:
__________________________________
Fax No: __________________________________
Email:
__________________________________
__________________________________
I am already an AC4R member
Yes / No
I am not a member at present
but would like to join
Yes / No
Membership is free for individuals. A fee is payable for
pharmaceutical companies not already members. .
Please email karyn.boundy@health.sa.gov.au for
membership of AC4R.
Registration Fee:
Registration Deadline:
$75.00 (Australian)
1st August 2010
Please note only LIMITED places are available –
on a first-come-first-served basis.
Please enclose this section and mail with your cheque
payable to AC4R “Australian Consortium of
Centres for Clinical Cognitive Research” to:
Dr Karyn Boundy
c/o: Memory Unit - Ward 5C
The Queen Elizabeth Hospital
28 Woodville Road
WOODVILLE SOUTH SA 5011